A decentralised care and the provision of free direct-acting antiviral agents (DAAs) can produce high rates of cure among people with hepatitis C virus (HCV) infection, according to a large-scale study conducted in India. [...]
An affordable hepatitis treatment for the developing world's population is being planned, with medics confident that the new anti-virals are close to commercial launch. The drugs are expected to retail for no more than $3.50 per dose.[...]
Patients with chronic hepatitis C virus (HCV) infection who achieve a sustained virological response (SVR) after direct-acting antiviral agent (DAA) treatment have lower all-cause mortality, according to a real-world study ...[...]
Two nationwide programmes in Georgia and Iceland, which were designed to eliminate hepatitis C virus (HCV) at the population level, have reported encouraging results, suggesting that these countries could be on target to ...[...]


Star ActiveStar ActiveStar ActiveStar ActiveStar Inactive